Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
CHAPTER 27   Dementia
TOPICS   Introduction ~ Alzheimer's Disease ~ Vascular Dementia ~ Lewy Body Dementia
grey line
 
Apolipoprotein E and Alzheimer's Disease

One of the genes involved in Alzheimer's disease affects a protein called apolipoprotein E (apo E). This protein is one part of lipoproteins, which transport cholesterol through the bloodstream. The gene determines which type of apo E a person has: ε2, ε3, or ε4. People with the ε4 type are more likely to develop Alzheimer's disease than other people. In contrast, people with the ε2 type may have some protection against Alzheimer's disease. People with the ε3 type are neither protected nor more likely to develop the disease. (These associations have been studied primarily in white people and may not apply to other races.) Genetic testing for apo E type cannot definitively determine whether a person will develop Alzheimer's disease. Therefore, this testing is not routinely recommended.

Back to Alzheimer's Disease.

Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.